Tangible nanocomposites with diverse properties for heart valve application by Vellayappan, Muthu Vignesh et al.
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=tsta20
Science and Technology of Advanced Materials
ISSN: 1468-6996 (Print) 1878-5514 (Online) Journal homepage: https://www.tandfonline.com/loi/tsta20
Tangible nanocomposites with diverse properties
for heart valve application
Muthu Vignesh Vellayappan, Arunpandian Balaji, Aruna Priyadarshini
Subramanian, Agnes Aruna John, Saravana Kumar Jaganathan, Selvakumar
Murugesan, Hemanth Mohandas, Eko Supriyanto & Mustafa Yusof
To cite this article: Muthu Vignesh Vellayappan, Arunpandian Balaji, Aruna Priyadarshini
Subramanian, Agnes Aruna John, Saravana Kumar Jaganathan, Selvakumar Murugesan, Hemanth
Mohandas, Eko Supriyanto & Mustafa Yusof (2015) Tangible nanocomposites with diverse
properties for heart valve application, Science and Technology of Advanced Materials, 16:3,
033504, DOI: 10.1088/1468-6996/16/3/033504
To link to this article:  https://doi.org/10.1088/1468-6996/16/3/033504
© 2015 National Institute for Materials
Science
Published online: 20 May 2015.
Submit your article to this journal Article views: 872
View related articles View Crossmark data
Citing articles: 5 View citing articles 
Review
Tangible nanocomposites with diverse






















1 IJN-UTM Cardiovascular Engineering Centre, Faculty of Biosciences and Medical Engineering,
Universiti Teknologi Malaysia, Johor Bahru 81310, Malaysia
2Rubber Technology Center, Indian Institute of Technology, Kharagpur, 721302, India
3Department of Biomedical Engineering, University of Texas Arlington, Texas, TX 76019, USA
E-mail: jaganathaniitkgp@gmail.com and saravana@utm.my
Received 19 January 2015, revised 4 March 2015
Accepted for publication 1 April 2015
Published 20 May 2015
Abstract
Cardiovascular disease claims millions of lives every year throughout the world. Biomaterials
are used widely for the treatment of this fatal disease. With the advent of nanotechnology, the
use of nanocomposites has become almost inevitable in the field of biomaterials. The versatile
properties of nanocomposites, such as improved durability and biocompatibility, make them an
ideal choice for various biomedical applications. Among the various nanocomposites, polyhedral
oligomeric silsesquioxane-poly(carbonate-urea)urethane, bacterial cellulose with polyvinyl
alcohol, carbon nanotubes, graphene oxide and nano-hydroxyapatite nanocomposites have
gained popularity as putative choices for biomaterials in cardiovascular applications owing to
their superior properties. In this review, various studies performed utilizing these
nanocomposites for improving the mechanical strength, anti-calcification potential and
hemocompatibility of heart valves are reviewed and summarized. The primary motive of this
work is to shed light on the emerging nanocomposites for heart valve applications. Furthermore,
we aim to promote the prospects of these nanocomposites in the campaign against cardiovascular
diseases.
Keywords: nanocomposites, heart-valve, hemocompatiblity, anti-calcification, mechanical-
strength
1. Introduction
Cardiovascular disease is a fatal disease and the health data
obtained from more than 190 countries show that heart dis-
ease is the number one global cause of death, with 17.3
million deaths every year according to the latest 2015 health
report. This number is predicted to increase to more than 23.6
million by the year 2030 [1]. As per the Euro Heart Survey,
aortic valve disease constitutes 44.3% of all cardiac valve
failures [2]. This makes the aortic valve replacement (AVR)
operation the second most common cardiac operation after
coronary artery bypass grafting [3]. Even though there have
been various advancements in AVR in terms of valve design,
surgical techniques and concomitant medication, the available
prostheses are still not able to meet essential characteristics
such as durability in the case of bioprosthetic heart valves
(BHVs) and thrombogenicity for mechanical heart
valves (MHVs).
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The development of cardiovascular heart valves demands
an in depth knowledge and understanding of the mechanical
and surface properties of the materials used for heart valve
design. Thus, the development of a substitute heart valve
mimicking the performance of the natural heart valves exactly
remains as a herculean challenge for biomedical engineers to
decipher. The ideal artificial heart valve must have certain
clinical and engineering features to perform efficiently. A
viable biomaterial which is completely functional and blood
compatible is the most vital factor to be considered when
designing and developing prosthetic heart valves. There is a
set of characteristics that have to be contemplated for
selecting a suitable prosthetic heart valve material. For
example, the surface of the heart valve material should cause
minimal or no damage to the circulating blood cells and to the
surrounding endothelial tissue of the cardiovascular structure.
The biomaterial utilized must exhibit excellent resistance to
mechanical and structural wear. The possibility of platelet and
thrombus deposition on the biomaterials should be small. The
material used should be non-degradable in the physiological
environment and must neither absorb blood constituents nor
release foreign particles into the blood stream. The heart valve
biomaterial should also be non-hemolytic, non-thrombogenic,
non-infectious, non-immunogenic, non-inflammatory and
non-calcifying. The two commonly used types of heart valves
are MHVs and BHVs. Currently, few bioengineering mate-
rials are suitable for MHVs and these have limited applica-
tions. Figure 1 depicts the various materials used for the
components of MHVs [4].
Synthetic leaflet heart valves (SLHV), including poly-
urethane (PU) valves, have been studied to develop a best
alternative to currently available cardiac valve prostheses.
This has be achieved by combining the more durable MHVs
and improved hemodynamic BHVs to overcome their lim-
itations. Desirable physical properties, affordable manu-
facturing and the same flow dynamics as human heart valves
made PU valves a plausible substitute for mechanical and
tissue prostheses. Conversely, they were not used as heart
valve replacements as they suffered premature failure because
of their sub-optimal design and the lack of a durable polymer
[5]. A few synthetic materials, such as silicon rubber, poly-
olefin, polytetrafluoroethylene (PTFE), poly(styrene-block-
isobutylene-block-styrene), ethylene propylene diene mono-
mer (M-class) rubber, polyvinyl alcohol (PVA) cryogel and
segmented PU elastomers have been tested as heart valve
leaflets [6–10]. However, these materials did not have suffi-
cient physical strength and the long-term biostability required
for heart valve prostheses. Thus, an unmet demand exists for
the development of new materials with enhanced properties
for heart valve development. Recent trends and advancements
in synthesis methods and structural modification, along with
the emergence of novel technologies such as nanotechnology,
have paved the way for the development of superior materials
called nanocomposites which can be explored for heart valve
applications.
Nanocomposites are materials which are produced by the
mixture of components at a nanometer scale. They are com-
posed of a minimum of two constituent materials which form
Figure 1. Biomaterials used for different heart valve components.
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the matrix or host plus a bolstering component called a
nanofiller or guest [11]. It is a well known fact that the
characteristics of a material change significantly when the size
is substantially smaller, in the range of 1–100 nm. As they are
quantum scale in size, they can serve as a connecting bridge
between molecules in the polymer. This makes it possible for
nanocomposites to display a different range of properties to
regular microcomposites.
Nanocomposite materials may be either organic, inor-
ganic or hybrid in composition [12]. Different examples of
nanocomposites which are naturally available are bone, aba-
lone shells and teeth. Inspired by the excellent properties of
natural nanocomposites, different studies have been per-
formed for producing synthetic nanocomposites. The syn-
thetic nanocomposites were expected to have the same
outstanding properties as natural nanocomposites [13, 14].
The technique which is used to create the nanocomposites is
the determining factor for the performance of the synthetic
nanocomposite material. For instance, different factors such
as production technique, the nature of the nanofiller, the
process used for nano-reinforcement and the type of reactions
involved between the polymeric and strengthening con-
stituents regulate the overall performance of the nano-
composite material [11]. There are different types of synthetic
nanocomposites and they can be segregated into four cate-
gories which are clay-, carbon-, metal- and glass-reinforced
[15]. Silicon and metal oxides (e.g. ZnO and TiO2) are used
frequently as nanofillers due to their superior mechanical
properties [16]. As the physical, chemical and mechanical
properties of nanomaterials are far better in comparison to
conventional biomaterials, they are putative choice for car-
diovascular applications.
Even though there are various problems associated with
heart valves, the leading problem is heart valve failure due to
mechanical stress, calcification of the heart valve and blood
compatibility issues [17]. Despite the fact that MHVs and
BHVs have been used for more than fifty years, no appreci-
able clinical outcome has yet been attained. The National
Institutes of Health (NIH) reported that the ten year mortality
rate for valve replacements still varies from 30–55%, indi-
cating the severity of the heart valve failure problem and
emphasizing the need for further improvements in valve
substitutes [18]. Thus, in this review the three vital issues
mentioned above for conventional heart valves are analyzed
thoroughly and the vital role nanocomposites can play in
tackling these issues is summarized.
2. Potential nanocomposites for cardiovascular
heart valve applications
Finding materials suitable for soft tissue replacement is a
significant aspect for heart valve design and fabrication. There
is a demand for a material that not only exhibits similar
mechanical properties as the heart valve it is replacing, but
also demonstrates improved life span, biocompatibility, and
low thrombogenicity and degree of calcification. In a recently
published work, the biomechanical properties of native and
tissue engineered heart valve constructs were compared [19].
It was shown that the uniaxial tensile mechanical properties,
the Young's modulus, ultimate tensile strength and strain at
the ultimate tensile stress of human native heart valves, in the
circumferential direction are 15MPa, 2.6 MPa and 22MPa,
respectively [20]. Similarly, the same three mechanical
properties of the native heart valve in the radial direction were
found to be 2MPa, 0.4 MPa and 30MPa, respectively [20].
These values indicate that the modulus of elasticity and the
ultimate tensile stress of heart valve leaflets are greater in the
circumferential direction compared to the radial direction. On
the other hand, a prominent difference was observed between
human heart valves and animal heart valves such as porcine
heart valves. The Young’s modulus, ultimate tensile strength
and strain at maximum tensile stress of a porcine heart valve
were found to be 7.78MPa, 16.8MPa and 10.80MPa in the
circumferential direction and 1.28MPa, 11.60MPa and
7.50MPa in the radial direction, respectively [21]. This shows
why animal heart valves are much weaker in comparison to
human native heart valves and dictates that xenograft valve
transplants in humans lack long-term durability. Hence, the
use of nanocomposites holds great potential for circumvent-
ing this mechanical property bottleneck, since the mechanical
property values of the nanocomposites are in the same range
or have greater mechanical strength values compared to the
native heart valve. Apart from the improved mechanical
properties, the improved hemocompatibility and anti-calcifi-
cation of nanocomposites allow us to envisage their appli-
cation in cardiovascular heart valves. There are numerous
nanocomposites which have emerged recently. Polyhedral
oligomeric silsesquioxane-poly(carbonate-urea)urethane
(POSS–PCU), bacterial cellulose (BC) with PVA, carbon
nanotubes (CNTs), graphene oxide (GO) and nano-hydro-
xyapatite (nHA) nanocomposites have gained popularity as
putative choices for biomaterials in cardiovascular applica-
tions owing to their superior properties. A succinct insight on
these nanocomposites is given in the following before we
discuss their putative role in heart valve applications.
POSS nanoparticles added to PCU, resulting in POSS–
PCU, has been developed for various surgical implant
applications. The chemical structure of the silsesquioxane
family is defined as RnSinO1.5n. Figure 2(a) shows the three-
dimensional structure of POSS which consists of an inner
inorganic framework of silicon (red) and oxygen (yellow)
atoms, externally covered by atoms of organic groups (grey)
and hydrogen atoms (white). This forms the cage structure of
the POSS. The inclusion of unique nanoscale POSS moieties
in PCU functions as a cross-linking agent and tailors the
physicochemical properties of this nanocomposite polymer in
comparison to conventional constituents [22]. POSS–PCU
was utilized for many vital biological applications such as the
world's first artificial trachea, lacrimal duct conduits and
lower limb bypass grafts, all of which are about to enter
clinical trials [23–25]. Thus, the application of the POSS–
PCU nanocomposite can be further extended for heart valve
development.
BC is a viable, sustainable and biodegradable nanofi-
brous material. The diameter of BC fibers ranges from
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40–70 nm and these fibers demonstrate various unique prop-
erties such as high purity, a better degree of polymerization
and excellent crystallinity, thereby giving them a high
strength and modulus [26–28]. The smaller fiber diameter of
BC confers a higher surface area and its porous structures
facilitate the retention of a large amount of water. BC also has
good thermal stability, outstanding environmental biode-
gradability and exceptional biocompatibility [26–28]. Owing
to its excellent properties, BC is used in a wide range of
applications such as artificial bones, skin, blood vessels, etc
[29, 30]. PVA is a hydrophilic biocompatible polymer. It has
the desired characteristics for biomedical applications. PVA
can be converted into a solid hydrogel with better mechanical
properties by physical crosslinking, using freeze–thaw cycles.
Thus, PVA combined with BC results in biocompatible
nanocomposites with synergetic properties. Figure 2(b) shows
the PVA–BC structure where the green strains are BC and the
brown strains represent the hydrophilic PVA strains which are
combined to form a PVA–BC nanocomposite. This PVA–BC
has a wide spectrum of mechanical properties and it can be
tailored to possess mechanical properties almost identical to
those of cardiovascular tissues such as heart valve leaflets.
Hence, we can exploit the superior properties of PVA–BC for
cardiovascular heart valve applications.
Graphene is a one atom layer of carbon and has received
enormous attention for its novel properties and plausible
applications in the field of materials science since it was first
reported in 2004 [31]. Graphene-based materials can be
synthesized in different forms such as GO, reduced GO and
exfoliated graphite, which guarantees its scalable production
and supply for a variety of applications. GO is an oxidized
graphene derivative which can be used as a substitute or
precursor for graphene materials owing to its high dis-
persibility and processability in aqueous environments
[32, 33]. It is produced from mineral graphite flakes via a
thermal oxidation method. Figure 2(c) shows the structure of
GO. GO has various functional groups such as epoxy,
hydroxyl and carboxyl groups, which make it strongly
hydrophilic. This makes it a good candidate for applications
in biomolecules, drugs and inorganic nanoparticles [34–37].
Moreover, graphene-based materials confer immense appli-
cation prospects in biomedicine. Hence, GO is a putative
candidate for the development of prosthetic heart valves.
A CNT can be considered as a seamless hollow tube
consisting of a graphite sheet where, depending on the
number of graphite sheet layers, the CNTs can be classified
into single-walled CNTs (SWCNTs) and multi-walled CNTs
(MWCNTs) [31, 38]. A SWCNT is a single molecular
Figure 2. Structures of fillers in nanocomposites for heart valve applications.
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nanomaterial, composed of only one layer, a rolled single
sheet of graphite (graphene) forming a molecular cylinder. Its
diameter and length vary in the ranges of 0.75–3 nm and l–
50 nm, respectively. A MWCNT consists of more than two
layers of curly graphite sheet, with diameters of 2–30 nm and
some even more than l00 nm. The distance between each
layer is approximately 0.42 nm. Figure 2(d) shows CNTs.
CNTs are widely used in various biomedical applications
such as biosensors and diagnostic agents to visualize cancer
cells etc, due to their biocompatible properties [39, 40].
Therefore, CNTs are also a potential candidate for the
development of cardiovascular heart valves.
nHA is one of the potential ceramic nanofillers with a
multitude of applications. It has a chemical structure of
Ca10(PO4)6(OH)2 and is referred to as a calcium phosphate
tribasic phase [41]. It is shown in figure 2(e). Recently, nHA
has gained momentum as an nHA-based filler reinforcement
for polymer matrices in biomedical applications such as tissue
engineering and bone implants. HA reinforced polymer
nanocomposites confer excellent biocompatibility in combi-
nation with enhanced mechanical properties such as improved
tensile and impact strength. It was found that the inclusion of
about 10% nHA by weight increases the stiffness and strength
of the polymeric matrix [42].
In the following sections, three vital issues—namely
mechanical strength, anti-calcification potential and hemo-
compatibility—will be addressed, citing the improvements
facilitated by using nanocomposites.
3. Nanocomposites for improving the mechanical
strength of prosthetic heart valves
From the perspective of structural and mechanical properties,
it is expected that when the heart valve is made up of a fiber
reinforced composite material which mimics the natural heart
valve structure and properties, it will minimize perforations,
leaflet stresses and tears. Commonly used materials, such as
poly(tetrafluoroethylene), polyvinyl chloride, segmented poly
(urethane), silicon rubber and poly(ether urethane urea), have
drawbacks such as fatigue, short life-span and durability [43].
The incorporation of novel nanocomposite materials in heart
valves to overcome these drawbacks is discussed in the
following.
Wan et al ascertained that BC fibers are very strong and
can be used for the development of cardiovascular heart
valves [44]. In their work, a nanocomposite was synthesized
by combining BC networks and calcium-deficient HA pow-
ders and the nanocomposite produced was then characterized.
The nHA nanoparticles were prepared via a wet chemical
precipitation method, commencing from aqueous solutions of
calcium nitrate and di-ammonium phosphate salts. Energy-
dispersive spectroscopy showed that the prepared HA was
calcium-deficient HA. BC–HA nanocomposites were then
prepared through the addition of carboxymethylcellulose
(CMC) to the bacteria culture medium. nHA nanoparticles
were then added and remained suspended in the culture
medium during the formation of cellulose nanofibrils. The
maximum gel thickness was observed after 21 days of bac-
teria cultivation. X-ray diffraction (XRD) results showed the
variation in crystallinity among the materials involved in the
formation of the nanocomposites. The inorganic and organic
bonds between the HA and BC were ascertained using atte-
nuated total reflectance Fourier transform infrared spectro-
scopy. Scanning electron microscopy (SEM) and atomic force
microscopy (AFM) analyses confirmed the formation of net-
works and fibers with minimum diameters corresponding to
BC synthesized in the presence of CMC. Qualitative analysis
was implemented to study the orientation distributions and
Feret diameters for networks of BC and BC–CMC. Ther-
mogravimetric analysis showed that the quantity of the
mineral phase was 23.7% of the total weight of the nano-
composite. These results indicate that there would be for-
mation of new networks and fibers with a smaller diameter
resulting in a good increase in the mechanical strength of the
resultant nanocomposite. Thus, this nanocomposite with
properties mimicking cardiovascular tissues can be con-
sidered as a potential candidate for synthetic replacements of
cardiovascular tissues such as heart valves.
Likewise, in a work by Millon and Wan, the effect of the
inclusion of BC in PVA and the mechanical properties of the
resulting nanocomposite was studied [45]. Surprisingly, the
resultant nanocomposite was found to possess excellent
mechanical properties, similar to those of cardiovascular tis-
sues such as heart valve leaflets. The stress–strain character-
istics of porcine aorta were matched by at least one type of
PVA–BC nanocomposite in either the circumferential or axial
tissue directions. A PVA–BC nanocomposite with same
mechanical characteristic as natural heart valve tissue was
developed in this study. The relaxation characteristics of
samples were also studied. The result shows that PVA–BC
relaxes at a faster rate and has a lower residual stress com-
pared to the natural tissues it replaces. Hence, the PVA–BC
composite can be promoted as a promising material for car-
diovascular heart valve applications.
Alongside the above studies, Kidane et al investigated
the mechanical properties of POSS–PCU, such as tensile
strength, tear resistance and hardness and then compared them
with normal PCU [46]. In addition to mechanical properties,
surface properties such as contact angles and platelet adhesion
resistance were assessed. It was found that POSS–PCU
(hardness 84.0 ± 0.8 Shore A) exhibited considerably greater
tensile strength (54 ± 3 and 56 ± 4 Nmm−2 at 25 °C and 37 °C,
respectively) in comparison to normal PCU (34 ± 2 and
29 ± 3 Nmm−2). Elasticity properties such as tensile strength,
elongation at break, and Young’s modulus were found to be
higher in the case of POSS–PCU than the control PCU at
25 °C and 37 °C. There was no significant difference
observed in the tear strength between POSS–PCU and the
control PCU at 25 °C; however, when the temperature was
increased to 37 °C POSS–PCU displayed superior tear
strength to PCU at a thickness of 200 μm
(63.0 ± 1.5 Nmm−1).
Xu et al demonstrated that the strength and hardness of
PCU increased with the inclusion of POSS particles into the
polymer matrix [47]. The improved tensile strength and
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hardness of POSS–PCU was believed to be due to the
inclusion of nanoscale POSS particles in the polymer matrix.
The special property of the POSS nanocomposites is that they
are held together by a strong intermolecular force between the
nanocomposite molecules and neighboring molecules. In
addition, a strong framework with shorter bond lengths exists
between the nanocomposites, providing them with additional
resistance to degradation. A POSS nanofiller will improve the
material’s transition temperature (Tg) at greater concentrations
by reducing the distance between nanofillers. As a result of
this, the molecular or segment rotation with respect to the
reference polymer will be decreased thereby making the
polymer more robust. The POSS-incorporated polymer’s
mechanical properties were studied at a higher temperature
and it was found that this mechanical property was retained.
Hence, POSS–PCU may be considered as a putative choice
for heart valve applications.
In addition to the studies on POSS–PCU discussed
above, Ghanbari et al showed that the glass transition tem-
perature (Tg) was found to be almost same for both PU and
POSS–PCU [48]. This is due to the fact that only a very low
percentage of POSS was added to the POSS–PCU. The per-
centage of POSS addition was only 2%. Similarly, the stress–
strain behaviors of both the POSS–PCU and PU were also
nearly the same but the maximum tensile strength and elon-
gation at the break were found to be smaller in PU than in
POSS–PCU. Thus, this property of POSS can be exploited to
enhance the long term durability of heart valves developed
from POSS–PCU. Likewise, Petrovic et al demonstrated that
the mechanical properties, such as maximum tensile strength
and elongation at the break, were improved in the case of PU
modified with POSS compared to the control PU [49].
CNTs have been characterized as having outstanding
mechanical properties. Both SWCNTs and MWCNTs have a
large Young’s modulus (1 TPa) because of their flexible
hexagonal network of carbon atoms [50, 51]. Thus, CNTs
have been added as bolstering agents in natural and synthetic
polymer matrices. It was observed that in these nanocompo-
sites, CNTs play an important role in enhancing the
mechanical and structural properties of polymer composites.
Poly (propylene fumarate) (PPF), which is a biodegradable
polyester, is a good polymeric biomaterial used for tissue
regeneration applications. It was found that the inclusion of
SWCNTs into the PPF polymer improves the mechanical
properties of PPF. The presence of very low concentrations of
SWCNTs (less than 0.5 wt%) in the PPF polymer matrix
significantly improves (up to two- to three-fold) the com-
pressive and flexural characteristics of the nanocomposite
compared to PPF alone [52]. Likewise, in a work carried out
by Guo et al, a general and effective method for fabricating
CNT–polymer fibers via the inclusion of monomers was
achieved. This was followed by an in situ polymerization.
The resulting nanocomposite demonstrated improved tensile
strength compared pure CNT fibers and CNT–polymer fibers
synthesized by the direct incorporation of polymers. Hence,
this nanocomposite can be considered in the development of
heart valves [53].
Zomer Volpato et al produced a MWCNT–polyamide 6
(PA6) nanocomposite and showed inclusion of up to 2 wt%
CNTs in CNT–PA6 laminates; this enhanced the flexural
stress of the laminates by up to 36%. The CNT was expected
to form hydrogen bonds between the polymer and filler or
form amide bonds among free amines on the polymer and the
CNT’s carboxyl groups [54]. The physiochemical properties
of PU have been improved by the inclusion of CNTs. For
example, Amr et al showed that the Young’s modulus of
CNT–polystyrene (PS) nanocomposites was improved by
22% [55]; Jung et al demonstrated that when the transparent
PU film was added to functionalized MWCNTs, it displayed
two- to ten-fold increases in tensile strength and Young’s
modulus for MWCNT–PU composite film [56]. Tjing et al
synthesized MWCNT–PU composites via electrospinning and
solution casting techniques. The physical and thermal prop-
erties and mechanical performance of the nanofiber as well as
the film composites were characterized and compared. The
results showed that incorporation of MWCNTs improved the
tensile strength and modulus of the composite nanofibers by
69% and 140%, respectively. On the other hand, for com-
posite films the results were only 62% and 78% improvement
in the tensile strength and modulus strength. The MWCNT–
PU nanocomposite demonstrated an enhanced mechanical
behavior with the addition of low MWCNT content. Hence,
these studies demonstrate that the mechanical strength of the
material improves tremendously with the inclusion of CNTs
and this can be exploited for cardiovascular heart valve
applications [57].
A few studies have shown that the mechanical char-
acteristic of alumina can be reinforced by the addition of
CNTs. As the mass fraction of CNTs was increased to
2.0 wt%, the tensile strength and Brinell hardness of the
nanocomposite were improved and it attained a maximum of
245MPa and 106.66 n mm−2, respectively. Ogihara et al
developed a CNT–alumina nanocomposite by direct growth
of CNTs on alumina via chemical vapor deposition and the
nanocomposites were densified by spark plasma sintering.
The mechanical strength was improved as follows: Young’s
modulus, 383 GPa; Vickers hardness, 19.9 GPa; and bending
strength, 578MPa [58]. For zirconia–MWCNT composites,
the inclusion of MWCNTs was expected to resist slow crack
propagation and to improve the toughness of the ceramic
material used for prostheses. The sample of zirconia–
MWCNTs demonstrated a higher density, a smaller grain
size, enhanced toughness and improved hardness, which
shows the desirable characteristics of MWCNTs as bolstering
agents for zirconia [59]. Hence all these results show that
different matrices impregnated with CNTs improve the
overall mechanical strength of the material, thereby warrant-
ing its potential for heart valve applications.
PVA hydrogels have been proposed as a viable bioma-
terial, yet these materials suffer from poor mechanical and
water-retention properties. In work carried out by Zhang et al,
the freeze–thaw method was utilized to add GO to PVA to
yield GO–PVA nanocomposite hydrogels [60]. The
mechanical properties of the GO–PVA hydrogels were sig-
nificantly improved. In comparison to pure PVA hydrogels, a
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132% improvement in tensile strength and a 36% enhance-
ment of compressive strength were achieved with inclusion of
0.8 wt% of GO. This work demonstrates that excellent load
transfer occurs between the GO and the PVA matrix, thereby
suggesting that the same can be achieved in the development
of heart valves with improved mechanical strength.
In work carried out by Jin et al, GO complexes with 2-
(methacryloyloxy)ethyl phosphorylcholine (GO–MPC), as
well as modified polyethylene GO–MPC (PE/GO–MPC)
nanocomposites used for biomedical applications were pro-
duced and tested [61]. The results indicated that the tensile
strength and elongation of the PE/GO–MPC nanocomposites
were improved by 15.5% and 97.3%, respectively. Nano-
composite films of nanocrystalline cellulose acetate (NCCA)
and GO were produced by Kabiri et al by combining NCCA
and GO sheets in a well-controlled manner [62]. By the
adjustment of GO content, various NCCA–GO nanocompo-
sites with 0.3–1 wt% of GO were obtained. The preparation of
nanocomposite films was performed using the solvent casting
method. The characterization results of microscopic and XRD
analysis showed that the GO nanosheets were uniformly
dispersed in the NCCA matrix. The mechanical property of
tensile strength of the resultant nanocomposites was studied.
It was found that the best GO composition of the sample
tested was 0.8 wt%, with a tensile strength of 157.49MPa,
where it demonstrated a 61.92% increase in tensile strength
compared with plain NCCA. Thus, these studies validate the
concept that these nanocomposites can be utilized to improve
the mechanical strength of heart valves.
In work carried out by Zhang et al, an epoxy resin
nanocomposite was added to 0.5, 1, 2 and 4 wt% pristine
graphene to improve the mechanical properties of epoxy resin
[63]. The modified GO nanoflakes were synthesized and
utilized to create carbon fiber-reinforced and glass fiber-
reinforced composite panels through a vacuum-assisted resin
transfer molding process. The mechanical properties of the
produced graphene composites were investigated as per the
ASTM standards. It was found that the examined properties
were enhanced consistently by an increase in the amount of
nano inclusions. Specifically, in the case of 4 wt% GO in the
resin, the tensile modulus, compressive strength and flexural
modulus of the carbon fiber composites were enhanced from
15% to 21%, 34% to 84% and 40% to 68%, respectively.
Similarly, the addition of 4 wt% pristine graphene in resin
resulted in the improvement of the tensile modulus, com-
pressive strength and flexural modulus of the carbon fiber
composites from 11% to 7%, 30% to 77%, and 34% to 58%,
respectively. Hence, the overall report suggests that the
pristine graphene and modified GO nanoflake nanocomposite
is a viable option to improve the mechanical strength which
can be exploited for heart valves.
In a study carried out by Selvakumar et al, two types of
2D nHA rod (unmodified and polypropylene glycol (PPG)-
wrapped) of different high aspect ratios were prepared using a
modified co-precipitation method in the absence of any
templates [64]. They were incorporated into a novel synthe-
sized thermoplastic PU (TPU) matrix based on polycarbonate
soft segments using in situ and ex situ techniques. High
resolution transmission electron microscopy images of the
prepared nHA and PPG–nHA crystals show that the mean
particle length and width of the nanorods differs from one
method to the other. The nanorods prepared using the PPG
assisted method displayed a greater aspect ratio with tre-
mendous uniformity in the length of individual rods. The
average aspect ratio of the nanofiller was determined to be
∼4.8 for the nHA and ∼8.5 for the PPG-wrapped nHA.
Moreover, it was found that the tensile strength, Young’s
modulus and percentage of elongation of the nHA filled TPUs
improved in comparison to pristine TPUs. The Young’s
moduli of the nanocomposites were enhanced by 388%,
240%, 124% and 116% for in situ TPU–nHA, in situ TPU–
PPG–nHa, ex situ TPU–PPG–nHA and ex situ TPU–nHA),
respectively. In addition, the elongation at the break also
improved for the nanocomposite systems. The prime reasons
for the appreciable enhancement in properties are the high
aspect ratio of nHA, the noncovalent surface modification of
nHA, polymer–filler affinity, the surface roughness of the
nHA rod and dispersion of the nanofiller. Hence, over all,
higher aspect ratio (∼8.5) nHA filled TPU exhibits better
properties. To conclude, the nanocomposites prepared using
in situ techniques demonstrate better properties compared to
the nanocomposites prepared using ex situ techniques. Hence,
the novel TPU–PPG-wrapped HA nanocomposites can be
used as promising biomaterials for heart valve development.
4. Nanocomposites for improving the anti-
calcification potential of prosthetic heart valves
Calcification is the prime factor in the failure of a bio-
prosthesis such as a heart valve. It makes the heart valve
vulnerable to structural failure and cusp tears. Bioprosthesis
calcification is the process by which the mineral crystalline
calcium phosphate and other calcium minerals deposit on the
heart valve’s surface due to chemical reactions between
aldehyde groups’ phospholipids and circulating calcium ions
[65]. The general sites for calcific deposition are the com-
missural and basal areas of cusps where the mechanical stress
exposure is highest in heart valves [65, 66]. In addition,
several physiological parameters are also found to contribute
to the calcification of heart valves [67]. Although many stu-
dies have been performed to develop a technique to minimize
the calcification rate on heart valves, the issue has not yet
been completely resolved [68–70]. Nanocomposites can be
considered as a plausible candidate to solve the issue of cal-
cification of heart valves.
In the work discussed previously [48], the anti-calcifi-
cation potential of the silsesquioxane nanocomposite polymer
was studied. In this work a novel nanocomposite polymeric
material, POSS–PCU, was developed and investigated using
an in vitro technique. Thin sheets of nanocomposite, glutar-
aldehyde-fixed bovine pericardium (BP) and PU were sub-
jected to a calcium solution. The calcium solution was
accelerated by an in vitro physiological pulsatile pressure
system for a duration of 31 days for 4 × 107 cycles. Then, the
samples were tested for calcification using x-rays, microscopy
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techniques and chemical assessment. The mechanical and
surface properties were determined using stress–strain beha-
vior tests. The surface morphology and hydrophobicity were
also studied. The results showed a difference in the calcifi-
cation extent between the nanocomposite, glutaraldehyde-
fixed BP and PU. It was found that glutaraldehyde-fixed BP
and PU had appreciable calcium deposition but the calcium
deposition on the nanocomposite was insignificant. In the
calcified BP it was observed that the maximum calcification
happened in regions of maximum mechanical stress in com-
parison to the peripheral regions near the clamping site. In the
case of the POSS–PCU nanocomposite sample, it was noticed
that there was no calcium deposition. However, quantitative
analysis showed that there was only a meager amount of
calcium present in the extracted solution. On the other hand,
the PU samples had more calcium deposition, identified
through x-ray and confocal microscopy studies. The quanti-
tative analysis of the PU sample showed that the calcium
present in the extracted solution was greater than that in the
POSS–PCU sample (p< 0.05). This result may be interpreted
as showing that the presence of POSS moieties in the PU
made it more vigorous against calcification. Moreover, it is
assumed that the POSS nanoparticles alter the surface calcium
binding by modification of calcium mobilization and crys-
tallization. This is illustrated in figure 3. The presence of
POSS nanoparticles increases the hydrophobicity of the sur-
face; thus it may be assumed that POSS has a repellent effect
on mineral deposition. The result of this study was further
supported by a study performed by Liao et al, where the
mechanical stress exerted on the implanted heart valves
played a vital role in onset and progression of calcifica-
tion [71].
5. Nanocomposites for improving the
hemocompatiblity of prosthetic heart valves
The hemocompatibility enhancement imparted by nano-
composites is highlighted in this section. A synthetic bio-
material experiences direct interaction with biological
systems, specifically in an aqueous environment such as the
cardiovascular system. It has an influence on peptide accu-
mulation, mineral deposition and cell adhesion on the bio-
material’s surface. It was found that a hydrophobic material
has better biocompatibility and lower cytotoxicity compared
to a hydrophilic material which has an analogous formulation
[72]. In addition, the hydrophobicity affects the protein
adsorption and platelet activation of the biomaterial. For
instance, the inclusion of hydrophobic phospholipid particles
in the biomaterial’s surface has reduced propensity of bio-
materials towards adsorption of bovine serum albumin and
bovine plasma fibrinogen, and adhesion and aggregation of
platelets [73].
Figure 3. Anti-calcification properties enhanced by POSS inclusion in PCU.
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Leitao et al performed a comprehensive blood compat-
ibility investigation of the PVA–BC nanocomposite through
the determination of whole blood clotting time, plasma
recalcification, factor XII activation, platelet adhesion and
hemolytic index [74]. The thrombogenicity and pro-coagu-
lative activity of BC and PVA–BC were studied by deter-
mining the whole blood clotting time. ePTFE was used as a
positive control and PS was utilized as a negative control. The
BC and the nanocomposite failed to display significant dif-
ferences, but they exhibited better values than the controls.
Similarly, the plasma recalcification analysis also showed no
improvement with the inclusion of PVA with BC; however,
both samples showed improved properties compared with the
controls. However, factor XII activation tests (intrinsic path-
way) and complement system activation tests demonstrated
improved activity of the PVA–BC nanocomposite compared
with both pristine BC and the controls. Surprisingly, the
extent of platelet adhesion was observed to be time depen-
dent; initially, after 10 min ePTFE (a control) showed traces
of platelet adhesion. BC and PVA–PC showed zero percen-
tage adhesion in the beginning but after 50 min the same
number of platelets were adhered as to ePTFE. This indicates
that in both samples, platelets were activated only after
50 min. This process was meticulously analyzed by mon-
itoring the signature of activated markers adhered to the
platelets. Furthermore, the result of the decreased hemolytic
index of the nanocomposite also suggests improved blood
compatibility for the PVA–BC nanocomposite. Thus, the
above results highlight the better rheological nature of the
synthesized nanocomposite, which can be exploited for heart
valve development.
The work undertaken by Kannan et al demonstrated the
antithrombogenic nature of POSS–PCU, where protein and
platelet adhesion were minimized [75]. It can be hypothesized
that the surface constituent and morphology are the con-
tributors to both the platelet and protein repellent activity.
This was observed in POSS–PCU nanocomposites. These
results are found to be in accordance with the findings of
other researchers showing that POSS modified the surface of
the PU layer by forming a silica layer on the surface of the PU
which protects the POSS–PCU from further degradation [76].
Inclusion of POSS in PU improved the hydrophobicity of PU.
It was found that the hydrophobicities of both PU and POSS–
PCU were increased from the contact angle results, which
increased due to exposure to the pulsatile flow system
(p< 0.05). This may have been due to an interaction between
the surface of the polymers and the electrolytes and ions
present in the surrounding solution. Surface roughness has a
significant effect on hydrophobicity. The Wenzel equation
states that the contact angle on the surface is associated with
the degree of ideal (true) contact and the roughness ratio (cos
θW= r cos θi). In this equation, θW is the Wenzel contact
angle, where the apparent contact angle at the global energy
minimum (GEM) θi is the ideal contact angle, and r is the
roughness ratio which is defined as the ratio between the true
and the apparent surface area of the solid. On a heterogeneous
surface, the contact angle at the GEM is related to the ideal
contact angle via the Cassie equation [77].
POSS–PCU displayed greater hydrophobicity than PU
when it was exposed to a calcium solution. The effect of
increased surface roughness and increased hydrophobicity in
POSS–PCU compared to PU may have triggered the lower
accumulation of calcium on the surface of the sample. Since
the measured contact angle for POSS–PCU is greater than for
PU, as per the Wenzel equation, the effect of changes in
roughness can be greater for POSS–PCU than PU.
A MWCNT–PU composite was developed via controlled
co-precipitation by Meng et al [78]. The surface chemical
constitution of the treated CNTs was examined using x-ray
photoelectron spectroscopy. Platelet adhesion and activation
of the composite were determined using SEM and flow
cytometric analysis, respectively, and the problems associated
with red blood cells were evaluated through the measurement
of the absorbance of free hemoglobin. The results of the study
show that MWCNTs with oxygen-containing functional
groups were evenly dispersed in the PU matrix via controlled
co-precipitation and the resultant nanocomposite surface
displayed an appreciably enhanced anticoagulant function,
which validates its viability in serving as a putative material
in the development of cardiovascular heart valves.
For heart valve applications, the design of a hemo-
compatible surface is required to reduce platelet surface
interactions and to improve the thromboresistance of the
surface. In a study by Dhandayuthapani et al, SWCNTs and
zein fibrous nanocomposite scaffolds were combined by
electrospinning and the antithrombogenicity and hydro-
philicity were analyzed [79]. Uniform and highly smooth
nanofibers of zein nanocomposite with different SWCNT
contents (ranging from 0.2 wt% to 1 wt%) were prepared
using an electrospinning technique without the occurrence of
bead defects. The resultant fiber diameters were 100–300 nm
without any beads. The characterization of the composite
nanofibers with and without SWCNTs was performed using
SEM, transmission electron microscopy, thermogravimetric
analysis and tensile mechanical testing. The hemolytic and
platelet adhesion characteristics of the nanocomposite zein–
SWCNTs were determined. The results showed that zein–
SWCNT composite scaffolds can be considered as a putative
antithrombotic material and a promising biomaterial for heart
valve applications.
In a study undertaken by Jin et al, a range of functional
GOs based on the biomimetic monomer 2-(methacryloyloxy)
ethyl phosphorylcholine (GO–g-pMPC) were synthesized by
reverse atom transfer radical polymerization in an alcoholic
medium using peroxide groups as the initiator [80]. This was
then filled into the PU matrix to obtain PU/functional GO
nanocomposite film (PU/GO–g-pMPC). The results showed
that the inclusion of a very small amount of GO can improve
the hemocompatible properties of PU. The hemocompatiblity
of the PU substrates was examined by protein adsorption tests
and platelet adhesion tests. The result showed that all the PU/
GO–g-pMPCs displayed enhanced resistance to nonspecific
protein adsorption and platelet adhesion.
Carboxylated GO (GO–COOH) with glutamic acid (Glu)
was prepared at different pH values by Zhou et al [81]. GO–
COOH/Glu was characterized by Fourier transform infrared
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Table 1. Nanocomposites used for cardiovascular heart valve applications.
Study No. Matrix material Nanofiller Key properties Reference
1 Bacteria culture media Hydroxyapatite (HA) powder, carboxymethylcellulose
(CMC) and nano-hydroxyapatite (nHA) nanoparticles
An increase in the mechanical strength of the resultant
nanocomposite.
[44]
2 Polyvinyl alcohol (PVA) Bacterial cellulose (BC) Improves the mechanical strength of the biocompatible
material.
[45]
A broader range of mechanical properties and higher
strength.
[65]
The blood compatibility of the PVA–BC nanocomposite was
improved.
[74]
3 Poly(carbonate-urea)urethane (PCU) Polyhedral oligomeric silsesquioxane (POSS) Improved tensile strength, tear resistance, hardness, elasticity
properties, tear resistance and hardness.
[46]
The strength and hardness of the PCU increased due to the
inclusion of POSS particles.
[47]
A strong framework with shorter bond lengths exists between
nanocomposites providing them with additional resistance
to degradation.
[47]
Enhancement of creep and compression set properties. [15]
The maximum tensile strength and elongation at the break
were found to be smaller in the PU than the POSS–PCU.
[48, 49]
Calcification occurred in regions of maximum mechanical
stress in comparison to the peripheral regions near the
clamping.
[71]
POSS nanoparticles increase the hydrophobicity of the sur-
face, thus it may be assumed that POSS has a repellent
effect on mineral deposition.
[58]
Protein and platelet adhesion was minimized. [75]
A silica layer on the surface of PU protects the POSS–PCU
from further degradation.
[76]
Inclusion of POSS in PU improved the hydrophobicity
of PU.
[76]
The roughness of the surface increases the contact angle. [77]
4 Poly(lactic-co-glycolic-acid) (PLGA) Carbon nanofibers (CNFs) Cardiomyocyte function increased on CNF-enriched
composites.
[83]
5 Propylene fumarate (PPF) Single-walled carbon nanotubes (SWCNTs) The inclusion of SWCNTs in the PPF polymer improves the
mechanical properties of the PPF.
[51]
Very low concentrations of SWCNTs in the PPF polymer
matrix improve the compressive and flexural character-
istics of the nanocomposite up to two- to threefold com-
pared to PPF alone.
[52]
6 Polymer fibers Carbon nanotubes (CNTs) Improved tensile strength compared to pure CNT fibers or
the CNT–polymer fibers synthesized.
[53]


















































Study No. Matrix material Nanofiller Key properties Reference
Inclusion of up to 2 wt% CNTs in CNT–PA6 laminates
enhanced the flexural stress of the laminates up to 36%.
[54]
8 Polystyrene (PS) CNTs Young’s modulus of CNT–PS nanocomposites was
improved by 22%.
[55]
9 Polyurethane (PU) MWCNTs Two-fold and ten-fold increases in tensile strength and
Young’s modulus.
[56]
The inclusion of MWCNTs improved the tensile strength and
modulus of the composite nanofibers by 69% and 140%.
[57]
10 Alumina CNTs The resultant nanocomposite surface displayed appreciably
enhanced anticoagulant function.
[78]
The mechanical strength was improved as follows: Young’s
modulus, 383 GPa; Vickers hardness, 19.9 GPa; and
bending strength, 578 MPa.
[58]
11 Zirconia MWCNTs Higher density, smaller grain size, enhanced toughness and
improved hardness.
[59]
12 Zein fibers SWCNTs Improved hemolytic and platelet adhesion characteristics. [79]
13 Polycarbonate based PU nHA Nanorods prepared using a PPG assisted method displayed a
greater aspect ratio and tremendous uniformity.
[64]
The tensile strength, Young’s modulus and percentage of
elongation of the nHA filled TPUs improved.
[64]
Cell spreading and cellular processes are improved for nHA
filled TPU.
[64]
Prothrombin time (PT) and activated partial thromboplastin
time (APTT) are increased.
[64]
Hemolysis of nanocomposite samples demonstrated less than
1% hemolysis.
[64]
14 PVA Graphene oxide (GO) A 132% improvement in tensile strength and a 36%
enhancement of compressive strength were achieved with




GO complexes The tensile strength and elongation of PE/GO–MPC nano-
composites were improved by 15.5 and 97.3%.
[61]
16 Nanocrystalline cellulose acetate (NCCA) GO A 61.92% increase in tensile strength compared with
plain NCCA.
[62]
17 Epoxy resin 0.5, 1, 2 and 4 wt % pristine graphene In the case of 4 wt % GO in the resin, the tensile modulus,
compressive strength and flexural modulus of carbon fiber
composites were enhanced by 15% (21%), 34% (84%) and
40% (68%), respectively.
[63]
18 2-(methacryloyloxy) ethyl phosphor-
ylcholine and PU(PU/GO–g-pMPC)
GO Inclusion of a very small amount of GO can improve the
mechanical properties of PU.
[80]


















































Study No. Matrix material Nanofiller Key properties Reference
19 Glutamic acid (Glu) Carboxylated GO (GO–COOH) Recalcification time was delayed greatly in the whole blood
and the hemolysis rates were lower than 5%.
[81]
20 Unfractioned heparin (UFH) Graphene Graphene–UFH conjugate displays an improved FXa activity
















































spectroscopy, XRD, thermogravimetry and zeta potential
measurements followed by blood compatibility analysis. The
results indicate that the complexes have a close relationship
with pH value owing to the presence of acid-responsive GO–
COOH/Glu complexes with Glu through amidation reactions
in the basic domain. The hemocompatiblity of GO–COOH/
Glu complexes was studied via hemolysis and recalcification
tests. The results showed that the plasma recalcification time
was delayed greatly in whole blood, and the hemolysis rates
were lower than 5%. Thus, GO–COOH/Glu complexes are
hemocompatible and this nanocomposite can be used as a
cardiovascular heart valve material.
In a study performed by Lee et al, the hemocompatibility
of a graphene–heparin conjugate was determined via non-
covalent interaction between chemically reduced graphene
and heparin [82]. The negative charge of heparin on graphene
plates enables the hydrophobic graphene to be solubilized in
aqueous media with the absence of precipitation or aggrega-
tion, even after six months. Unfractioned heparin (UFH) with
a high molecular weight was efficient for graphene solubili-
zation whilst low molecular weight heparin was poor for
graphene solubilization. Noncovalent interaction of heparin
chains on graphene plates conserves their anticoagulant
activity even after conjugation with graphene. Graphene–
UFH conjugate displays an improved anti-factor Xa (FXa)
activity of 29.6 IU mL−1 compared with pristine GO
(1.03 IU mL−1) which can be exploited for cardiovascular
heart valve applications.
Carbon nanofibers (CNFs) embedded in poly(lactic-co-
glycolic-acid) (PLGA) were found to promote cardiomyocyte
growth compared to the conventional polymer substrate and
the mechanism involved was also studied [83]. In this work,
CNFs were added to biodegradable PLGA (50:50 PGA:PLA
weight ratio) to improve the conductivity, and mechanical and
cytocompatibility properties of pure PLGA. Different PLGA
to CNF ratios (100:0, 75:25, 50:50, 25:75 and 0:100 wt%)
with varying PLGA densities (0.1, 0.05, 0.025 and
0.0125 g mL−1) were utilized, and their compatibility with
cardiomyocytes was studied. Among different cytocompat-
ibility tests, it was found that cardiomyocytes were viable and
expressed vital biomarkers, such as cardiac troponin T, con-
nexin-43 and alpha-sarcomeric actin. Adhesion and pro-
liferation tests displayed a PLGA density of 0.025 g mL−1
with PLGA to CNF ratios of 75:25 and 50:50 (wt%) pro-
moting the best overall cell growth, which is a 55%
improvement in cardiomyocyte density after 120 h in com-
parison to pure PLGA and a 75% improvement in cardio-
myocyte density compared to the control at the same time
point for 50:50 (wt%). AFM revealed that the addition of
CNFs to PLGA increased the material surface area from 10%
(100:0; PLGA to carbon nanofiber (wt%:wt%)) to more than
60% (50:50; PLGA to carbon nanofibers (wt%:wt%)). Fur-
thermore, the adsorption of specific proteins such as fibro-
nectin and vitronectin demonstrated more adsorption for the
50:50 PLGA to CNF (wt%:wt%) ratio at 0.025 g mL−1 PLGA
in comparison to pure PLGA, and shows that the cardio-
myocyte function increased on CNF-enriched composites.
Thus, this work indicates that cardiomyocyte function was
improved with 50:50 PLGA to CNF (wt%:wt%) composite
ratios at 0.025 g mL−1 PLGA densities since they mimicked
native heart valves and improved the adsorption of proteins
known to promote cardiomyocyte function.
As a continuation to the previously discussed study by
Selvakumar et al, the optical densities of MG63 cell pro-
liferation on the surfaces of pristine TPU and nanocomposites
were studied after 1, 5 and 7 days [64]. Cell proliferation was
noticeable over time. This suggests that more favorable cell
growth was observed on the surface of in situ TPU–PPG–
nHA nanocomposites compared to the nanocomposites pre-
pared via an ex situ technique such as TPU–nHA. This is
mainly due to the interfacial adhesion between the nHA and
TPU matrix. The field emission SEM images of MG63 cells
cultured and fixed after 7 days show that cell spreading and
cellular processes are improved on the nHA filled TPU
nanocomposite surface. Either the prothrombin time (PT) or
activated partial thromboplastin time (APTT) of the nano-
composites samples were increased in comparison to the
pristine TPU. Statistical analysis of the pristine TPU per-
formed using one-way ANOVA indicates appreciable differ-
ences (p< 0.05) between TPU and the nanocomposites for
both PT and APTT times. The hemolysis assay showed that
pristine TPU triggered 12% hemolysis; however the nano-
composite samples demonstrated less than 1% hemolysis.
Specifically, in situ prepared samples showed only 0.3%
hemolysis, and this shows that antithrombotic activity is
exceptionally good for such nanocomposites. Thus, they can
also be described as nonhemolytic materials. To conclude,
nHA filled TPU composites increase the time taken for blood
coagulation and also minimizes the hemolysis ratio greatly,
specifically for in situ prepared nanocomposites of both fillers
(nHA and polymer wrapped nHA). Different factors deter-
mining the blood compatibility are the degree of hydro-
philicity, the surface roughness of filler and of course the
biocompatibility of nHA, etc. Hence, these novel nano-
composites can be utilized for blood interacting applications
because of their favorable hemocompatibility as well as their
excellent antithrombotic properties. Thus, we envisage that
the novel TPU–PPG-wrapped HA nanocomposites hold great
potential for biomedical applications, especially for cardio-
vascular heart valves.
6. Discussion
Nanocomposites with excellent properties have been intro-
duced with the latest advancements in nanotechnology. These
nanocomposites can be considered for various biomedical
applications, particularly cardiovascular applications, which
are currently in high demand. The results of each study per-
formed on different nanocomposites along with their key
properties are collected in table 1. Figure 4 illustrates the
properties enhanced by the nanocomposites for heart valve
applications. From the thorough analysis of these different
studies, it can be concluded that the MWCNT–PU, GO–PVA
and POSS–PCU nanocomposites are the most promising for
bolstering the mechanical strength of prosthetic heart valves.
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This is because the inclusion of MWCNTs was shown to
improve the tensile strength and modulus of the composite
nanofibers by 69% and 140%, and produce a ten-fold increase
in Young’s modulus. GO incorporation with PVA also
resulted in a 132% improvement in tensile strength and a 36%
enhancement of compressive strength with the inclusion of
0.8 wt% of GO in PVA. Despite possessing good mechanical
properties, nanocomposites are the focus of debate regarding
their potential toxicity and few reviews have been published
on this topic [84–89]. For instance, in a recent work, CNTs
were shown in some cases to induce genotoxic effects [90].
However, another in vivo study of the biological response to a
CNT network was performed in the zebrafish model [91]. It
was found that while pristine CNTs had been previously
found to exert genotoxic effects in vitro, the CNT network
was not genotoxic in vivo. Thus, a consensus has yet to be
achieved because conflicting results have been obtained in
toxicology studies [92, 93] The lack of standardized protocols
as well as the variability of nanocomposites used in different
studies is the main reason for this discrepancy [92–98]. In
fact, there is also evidence that shows that the responses of
cells to nanofillers such as CNTs are modulated by their
physico-chemical properties and functionalization [99, 100].
Hence, looking at this evidence from a different viewpoint,
the possibility of reducing the toxicity of some nanofillers
such as CNTs and GO by modifying their physico-chemical
properties circumvents the problems of designing safe CNTs
and GO, opening up their prospects for secure and improved
nanocomposite heart valves.
The anti-calcification effect was observed most in the
case of POSS–PCU compared to other available nano-
composites because the POSS nanoparticles increase the
hydrophobicity of the surface; thus it may be assumed that
POSS may have a repellent effect on mineral deposition.
However, the role of other nanocomposites such as CNTs,
GO and BC should not be ignored as the studies related to the
anti-calcification potential of these composites have not been
analyzed exhaustively. Hence, it is recommended that some
comparative trials of the various nanocomposites are initiated
in order to obtain a better understanding of anti-calcification
potential. In the case of nHA, there is a general perception
that it may exhibit calcification. However, the works utilizing
nHA as a filler discussed in this review showed that the
inclusion of only 1 wt% in the matrix polymer was found to
have promising results in improving the mechanical as well
blood compatibility properties of the matrix material [64]. In
fact, in a recent work performed by Chen et al, poly(ε-
caprolactone) nanofibers with similar diameters (340 ± 30 nm)
Figure 4. Properties enhanced by nanocomposites for heart valve applications.
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but different nHA concentrations (0–50%) were fabricated
and the effect of the nHA concentration on mineralization was
investigated. The mineralization extent was found to be
highest in nanofibers with 50% nHA [101]. Another in vivo
work shows that the apatite mineral crystals are deposited
most on the polymer–HA nanocomposites with higher nHA
nanofiller content [102]. Hence, when the inclusion of nHA is
at a very low quantity such as 1 wt%, as discussed, this may
not pose a significant threat of calcification.
From the blood compatibility enhancement studies, it
was found that CNFs embedded in PLGA can be a plausible
candidate since cardiomyocyte function increases on CNF-
enriched composites. Likewise, the exhaustive analysis of
works performed using POSS–PCU shows that this nano-
composite may have good blood compatibility. This is
because protein and platelet adhesion was minimized in
POSS–PCU, which also had an increased surface roughness.
Moreover, CNTs or CNFs embedded in a biodegradable
polymer exhibit biocompatibility even after release into blood
vessels. The work carried out by Sitharaman et al showed that
the in vivo biocompatibility of ultra-short SWCNT/PPF
nanocomposites is similar to that of PPF alone, and the tissue
response they elicit is similar to that of other polymers and
nanocomposites used for tissue engineering [52, 103–106].
Hence, it is anticipated that CNTs or CNFs embedded in
biodegradable polymers do not pose a threat to biocompat-
ibility. Similarly, in work carried out by Edwards et al
MWCNT yarn and a composite scaffold of MWCNT/PLGA,
formed by electrospinning PLGA nanofibers, were investi-
gated for in vitro biocompatibility with NR6 mouse fibroblast
cells for up to 22 days. The results indicated that even the
MWCNT yarn supported cell growth throughout the culture
period, with fibroblasts attaching to and proliferating on the
yarn surface, indicating its biocompatibility [107].
In addition to this, the problem of biodegradability as
well as biocompatibility can be addressed by functionaliza-
tion of CNTs. Different approaches have been developed to
make CNTs biocompatible and to modulate any ensuing toxic
effects. Although chemically functionalized CNTs display
reduced toxicity, they are still considered with skepticism
owing to their perceived non-biodegradability. In a recent
work, it was demonstrated that functionalized CNTs can be
degraded by oxidative enzymes [99]. In addition, the bio-
compatibility and low cytotoxicity of CNTs are attributable to
size, dose, duration, testing systems and surface functionali-
zation. The functionalization of CNTs enhances their solu-
bility and biocompatibility and modifies their cellular
interaction pathways, resulting in much-reduced cytotoxic
effects and improved biocompatibility [100]. Thus, when
functionalized CNTs are used for heart valves, they will
exhibit biocompatibility even after release into blood vessels
due to the degradation of polymers.
7. Conclusions
Recently, nanocomposites utilizing POSS–PCU, BC, CNTs,
GO and nHA have been explored for heart valve applications.
Desirable properties are enhanced by the inclusion of nano-
fillers in the resultant nanocomposites, shown in figure 5. It
was found that these nanocomposites can play a key role in
improving heart valve mechanical strength, anti-calcification
potential and hemocompatibility. However, which nano-
composite offers the best potential for heart valves is still
largely a matter of conjecture. This is due to the lack of
studies of different nanocomposites with identical experi-
mental and clinical settings. There are still vital challenges
such as material costs, design and processing, longevity, and
health and safety approvals to tackle, in order to establish the
functionality and efficiency of these novel nanocomposites as
heart valve materials. We anticipate that synergetic efforts of
engineers, biologists and surgeons will be required to design
clinically available nanocomposite heart valves.
Acknowledgments
This work was supported partly by the Ministry of Higher
Education Malaysia with the Grant Vot No:R.
J130000.7809.4F444. The authors acknowledge UPMU and
UTM for support.
References
[1] 2014 American Heart Association statistical report tracks
global figures for first time (http://blog.heart.org/american-
heart-association-statistical-report-tracks-global-figures-first-
time/)
[2] Iung B et al 2003 A prospective survey of patients with
valvular heart disease in Europe: the euro heart survey on
valvular heart disease Eur. Heart J. 24 1231–43
[3] Roberts W C and Ko J M 2005 Frequency by decades of
unicuspid, bicuspid, and tricuspid aortic valves in adults
having isolated aortic valve replacement for aortic stenosis,
Figure 5. Properties enhanced by inclusion of nanofillers in the
resultant nanocomposites.
15
Sci. Technol. Adv. Mater. 16 (2015) 033504 M V Vellayappan et al
with or without associated aortic regurgitation Circulation
111 920–5
[4] Mohammadi H and Mequanint K 2011 Prosthetic aortic heart
valves: modeling and design Med. Eng. Phys. 33 131–47
[5] Ghanbari H, Viatge H, Kidane A G, Burriesci G,
Tavakoli M and Seifalian A M 2009 Polymeric heart valves:
new materials, emerging hopes Trends Biotechnol. 27
359–67
[6] Gallocher S L, Aguirre A F, Kasyanov V, Pinchuk L and
Schoephoerster R T 2006 A novel polymer for potential use
in a trileaflet heart valve J. Biomed. Mater. Res. Part B Appl.
Biomater. 79 325–34
[7] Wang Q, McGoron A J, Bianco R, Kato Y, Pinchuk L and
Schoephoerster R T 2010 In vivo assessment of a novel
polymer (SIBS) trileaflet heart valve J. Heart Valve Disease
19 499–505
[8] Cacciola G, Peters G W and Baaijens F P 2000 A synthetic
fiber-reinforced stentless heart valve J. Biomech. 33 653–8
[9] Jiang H, Campbell G, Boughner D, Wan W K and Quantz M
2004 Design and manufacture of a polyvinyl alcohol (PVA)
cryogel tri-leaflet heart valve prosthesis Med. Eng. Phys. 26
269–77
[10] Wheatley D J, Raco L, Bernacca G M, Sim I, Belcher P R and
Boyd J S 2000 Polyurethane: material for the next
generation of heart valve prostheses? European J. Cardio-
Thoracic Surgery: Official J. Eur. Assoc. Cardio-Thoracic
Surgery 17 440–8
[11] Kannan R Y, Salacinski H J, Butler P E and Seifalian A M
2005 Polyhedral oligomeric silsesquioxane nanocomposites:
the next generation material for biomedical applications Acc.
Chem. Res. 38 879–84
[12] Huang H, Yuan Q and Yang X 2005 Morphology study of
gold-chitosan nanocomposites J. Colloid Interface Sci. 282
26–31
[13] Meng G, Cao A, Cheng J Y and Ajayan P M 2004 Carbon
nanotubes grafted on silicon oxide nanowires J. Nanosci.
Nanotechnol. 4 712–5
[14] Suhr J, Koratkar N, Keblinski P and Ajayan P 2005
Viscoelasticity in carbon nanotube composites Nat. Mater. 4
134–7
[15] Liu Y L, Hsu C Y, Su Y H and Lai J Y 2005 Chitosan–silica
complex membranes from sulfonic acid functionalized silica
nanoparticles for pervaporation dehydration of ethanol–
water solutions Biomacromolecules 6 368–73
[16] Yang H G and Zeng H C 2005 Synthetic architectures of
TiO2/H2Ti5O11.H2O, ZnO/H2Ti5O11.H2O, ZnO/TiO2/
H2Ti5O11.H2O, and ZnO/TiO2 nanocomposites J. Am.
Chem. Soc. 127 270–8
[17] Mackay T G, Wheatley D J, Bernacca G M, Fisher A C and
Hindle C S 1996 New polyurethane heart valve prosthesis:
design, manufacture and evaluation Biomaterials 17
1857–63
[18] Edmunds L H Jr et al 1997 Directions for improvement of
substitute heart valves: national heart, lung, and blood
institute's working group report on heart valves J. Biomed.
Mater. Res. 38 263–6
[19] Hasan A et al 2014 Biomechanical properties of native and
tissue engineered heart valve constructs J. Biomech. 47
1949–63
[20] Balguid A et al 2007 The role of collagen cross-links in
biomechanical behavior of human aortic heart valve leaflets–
relevance for tissue engineering Tissue Engineering 13
1501–11
[21] Mavrilas D and Missirlis Y 1991 An approach to the
optimization of preparation of bioprosthetic heart valves
J. Biomech. 24 331–9
[22] Nayyer L, Birchall M, Seifalian A M and Jell G 2014 Design
and development of nanocomposite scaffolds for auricular
reconstruction Nanomed.: Nanotechnol., Biol. Med. 10
235–46
[23] Jungebluth P et al 2011 Tracheobronchial transplantation
with a stem-cell-seeded bioartificial nanocomposite: a proof-
of-concept study The Lancet 378 1997–2004
[24] Chaloupka K, Motwani M and Seifalian A M 2011
Development of a new lacrimal drainage conduit using
POSS nanocomposite Biotechnol. Appl. Biochem. 58
363–70
[25] Farhatnia Y, Tan A, Motiwala A, Cousins B G and
Seifalian A M 2013 Evolution of covered stents in the
contemporary era: clinical application, materials and
manufacturing strategies using nanotechnology Biotechnol.
Adv. 31 524–42
[26] Iguchi M, Yamanaka S and Budhiono A 2000 Bacterial
cellulose—a masterpiece of nature’s arts J. Mater. Sci. 35
261–70
[27] Backdahl H et al 2006 Mechanical properties of bacterial
cellulose and interactions with smooth muscle cells
Biomaterials 27 2141–9
[28] Klemm D, Schumann D, Udhardt U and Marsch S 2001
Bacterial synthesized cellulose—artificial blood vessels for
microsurgery Prog. Polym. Sci. 26 1561–603
[29] Lin N and Dufresne A 2014 Nanocellulose in biomedicine:
current status and future prospect Eur. Polym. J. 59 302–25
[30] Wan Y Z et al 2006 Synthesis and characterization of
hydroxyapatite–bacterial cellulose nanocomposites Compos.
Sci. Technol. 66 1825–32
[31] Kalbacova M, Kalbac M, Dunsch L, Kataura H and
Hempel U 2006 The study of the interaction of human
mesenchymal stem cells and monocytes/macrophages with
single-walled carbon nanotube films Phys. Status Solidi (B)
243 3514–8
[32] Li C, Adamcik J and Mezzenga R 2012 Biodegradable
nanocomposites of amyloid fibrils and graphene with shape-
memory and enzyme-sensing properties Nat. Nanotechnol. 7
421–7
[33] Compton O C et al 2012 Additive-free hydrogelation of
graphene oxide by ultrasonication Carbon 50 3399–406
[34] Dreyer D R, Park S, Bielawski C W and Ruoff R S 2010 The
chemistry of graphene oxide Chem. Soc. Rev. 39 228–40
[35] Lee W H et al 2012 Simultaneous transfer and doping of
CVD-grown graphene by fluoropolymer for transparent
conductive films on plastic ACS Nano 6 1284–90
[36] Myung S, Park J, Lee H, Kim K S and Hong S 2010
Ambipolar memory devices based on reduced graphene
oxide and nanoparticles Adv. Mater. 22 2045–9
[37] Lee W H et al 2012 Selective-area fluorination of graphene
with fluoropolymer and laser irradiation Nano Lett. 12
2374–8
[38] Lin Y et al 2004 Advances toward bioapplications of carbon
nanotubes J. Mater. Chem. 14 527–41
[39] Yang N, Chen X, Ren T, Zhang P and Yang D 2015 Carbon
nanotube based biosensors Sensors and Actuators B:
Chemical A 207 690–715
[40] Baslak C, Demirel Kars M, Karaman M, Kus M,
Cengeloglu Y and Ersoz M 2015 Biocompatible multi-
walled carbon nanotube–CdTe quantum dot–polymer
hybrids for medical applications J. Lumin. 160 9–15
[41] Sahana H, Khajuria D K, Razdan R, Mahapatra D, Bhat M,
Suresh S et al 2013 Improvement in bone properties by
using risedronate adsorbed hydroxyapatite novel
nanoparticle based formulation in a rat model of
osteoporosis J. Biomed. Nanotechnol. 9 193–201
[42] De Santis R et al 2011 A basic approach toward the
development of nanocomposite magnetic scaffolds for
advanced bone tissue engineering J. Appl. Polym. Sci. 122
3599–605
16
Sci. Technol. Adv. Mater. 16 (2015) 033504 M V Vellayappan et al
[43] Bezuidenhout D, Williams D F and Zilla P 2015 Polymeric
heart valves for surgical implantation, catheter-based
technologies and heart assist devices Biomaterials 36 6–25
[44] Wan W K, Hutter J L, Milton L and Guhados G 2006
Bacterial cellulose and its nanocomposites for biomedical
applications cellulose nanocomposites ACS Symposium
Series 938 221–41
[45] Millon L E and Wan W K 2006 The polyvinyl alcohol-
bacterial cellulose system as a new nanocomposite for
biomedical applications J. Biomed. Mater. Res. Part B Appl.
Biomater. 79 245–53
[46] Kidane A G, Burriesci G, Edirisinghe M, Ghanbari H,
Bonhoeffer P and Seifalian A M 2009 A novel
nanocomposite polymer for development of synthetic heart
valve leaflets Acta Biomaterialia 5 2409–17
[47] Xu H, Kuo S-W, Lee J-S and Chang F-C 2002 Preparations,
thermal properties, and Tg increase mechanism of inorganic/
organic hybrid polymers based on polyhedral oligomeric
silsesquioxanes Macromolecules 35 8788–93
[48] Ghanbari H, Kidane A G, Burriesci G, Ramesh B,
Darbyshire A and Seifalian A M 2010 The anti-calcification
potential of a silsesquioxane nanocomposite polymer under
in vitro conditions: potential material for synthetic leaflet
heart valve Acta Biomaterialia 6 4249–60
[49] Petrović Z S, Javni I, Waddon A and Bánhegyi G 2000
Structure and properties of polyurethane–silica
nanocomposites J. Appl. Polym. Sci. 76 133–51
[50] Kashyap K T and Patil R G 2008 On Young’s modulus of
multi-walled carbon nanotubes Bull. Mater. Sci. 31 185–7
[51] Deng L, Eichhorn S J, Kao C-C and Young R J 2011 The
Effective Young’s modulus of carbon nanotubes in
composites ACS Appl. Mater. Interfaces 3 433–40
[52] Sitharaman B et al 2008 In vivo biocompatibility of ultra-
short single-walled carbon nanotube/biodegradable polymer
nanocomposites for bone tissue engineering Bone 43 362–70
[53] Guo W, Liu C, Sun X, Yang Z, Kia H G and Peng H 2012
Aligned carbon nanotube/polymer composite fibers with
improved mechanical strength and electrical conductivity
J. Mater. Chem. 22 903–8
[54] Zomer Volpato F, Fernandes Ramos S L, Motta A and
Migliaresi C 2011 Physical and in vitro biological evaluation
of a PA 6/MWCNT electrospun composite for biomedical
applications J. Bioact. Compat. Polym. 26 35–47
[55] Amr I T et al 2011 Effect of acid treated carbon nanotubes on
mechanical, rheological and thermal properties of
polystyrene nanocomposites Composites Part B:
Engineering 42 1554–61
[56] Jung Y C et al 2010 Optically active multi-walled carbon
nanotubes for transparent, conductive memory-shape
polyurethane film Macromolecules 43 6106–12
[57] Tijing L D et al 2013 Characterization and mechanical
performance comparison of multi-walled carbon nanotube/
polyurethane composites fabricated by electrospinning and
solution casting Composites Part B: Engineering 44
613–9
[58] Ogihara N et al 2012 Biocompatibility and bone tissue
compatibility of alumina ceramics reinforced with carbon
nanotubes Nanomedicine 7 981–93
[59] Garmendia N, Santacruz I, Moreno R and Obieta I 2010
Zirconia-MWCNT nanocomposites for biomedical
applications obtained by colloidal processing J. Mater Sci.:
Mater Med. 21 1445–51
[60] Zhang L et al 2011 High strength graphene oxide/polyvinyl
alcohol composite hydrogels J. Mater. Chem. 21
10399–406
[61] Jin S, Xu D, Zhou N, Yuan J and Shen J 2013 Antibacterial
and anticoagulation properties of polyethylene/geneO-MPC
nanocomposites J. Appl. Polym. Sci. 129 884–91
[62] Kabiri R and Namazi H 2014 Nanocrystalline cellulose
acetate (NCCA)/graphene oxide (GO) nanocomposites with
enhanced mechanical properties and barrier against water
vapor Cellulose 21 3527–39
[63] Zhang B, Asmatulu R, Soltani S A, Le L N and Kumar S S A
2014 Mechanical and thermal properties of hierarchical
composites enhanced by pristine graphene and graphene
oxide nanoinclusions J. Appl. Polym. Sci. 131 1–8
[64] Selvakumar M, Jaganathan S K, Nando G B and
Chattopadhyay S 2015 Synthesis and characterization of
novel polycarbonate based polyurethane/polymer wrapped
hydroxyapatite nanocomposites: mechanical properties,
osteoconductivity and biocompatibility J. Biomed.
Nanotechnol. 11 291–305
[65] Schoen F J and Levy R J 2005 Calcification of tissue heart
valve substitutes: progress toward understanding and
prevention Annal. Thoracic Surgery 79 1072–80
[66] Butany J and Leask R 2001 The failure modes of biological
prosthetic heart valves J. Long-Term Effects of Medical
Implants 11 115–35
[67] Lee C H 2009 Physiological variables involved in heart valve
substitute calcification Expert Opin. Biological Therapy 9
1031–42
[68] Clark J N, Ogle M F, Ashworth P, Bianco R W and Levy R J
2005 Prevention of calcification of bioprosthetic heart valve
cusp and aortic wall with ethanol and aluminum chloride
Annal. Thoracic Surgery 79 897–904
[69] Everaerts F et al 2006 Reduction of calcification of
carbodiimide-processed heart valve tissue by prior blocking
of amine groups with monoaldehydes J. Heart Valve
Disease 15 269–77
[70] Sucu N et al 2004 Inhibition of calcification with citric acid in
pericardial bioprosthetic heart valve material: a preliminary
report J. Heart Valve Disease 13 697–700
[71] Liao K K et al 2008 Mechanical stress: an independent
determinant of early bioprosthetic calcification in humans
Annal. Thoracic Surgery 86 491–5
[72] Jansen E J et al 2005 Hydrophobicity as a design criterion for
polymer scaffolds in bone tissue engineering Biomaterials
26 4423–31
[73] Lv J-A, Ma J-N, Huang Fu P-B, Yang S and Gong Y-K 2008
Surface modification with both phosphorylcholine and
stearyl groups to adjust hydrophilicity and hydrophobicity
Appl. Surf. Sci. 255 498–501
[74] Leitao A F, Gupta S, Silva J P, Reviakine I and Gama M 2013
Hemocompatibility study of a bacterial cellulose/polyvinyl
alcohol nanocomposite Colloids Surf. B 111 493–502
[75] Kannan R Y et al 2006 The antithrombogenic potential of a
polyhedral oligomeric silsesquioxane (POSS)
nanocomposite Biomacromolecules 7 215–23
[76] Gonzalez R I, Phillips S H and Hoflund G B 2000 In situ
oxygen-atom erosion study of polyhedral oligomeric
silsesquioxane-siloxane copolymer J. Spacecr. Rockets 37
463–7
[77] Cassie A B 1948 Contact angles Discuss. Faraday Soc. 3
11–6
[78] Meng J, Kong H, Xu H Y, Song L, Wang C Y and Xie S S
2005 Improving the blood compatibility of polyurethane
using carbon nanotubes as fillers and its implications to
cardiovascular surgery J. Biomed. Mater. Res. Part A 74
208–14
[79] Dhandayuthapani B, Varghese S H, Aswathy R G,
Yoshida Y, Maekawa T and Sakthikumar D 2012
Evaluation of antithrombogenicity and hydrophilicity on
zein-SWCNT electrospun fibrous nanocomposite scaffolds
Int. J. Biomater. 2012 10
[80] Jin S X et al 2013 Synthesis and anticoagulation activities of
polymer/functional graphene oxide nanocomposites via
17
Sci. Technol. Adv. Mater. 16 (2015) 033504 M V Vellayappan et al
reverse atom transfer radical polymerization (ratrp) Colloids
Surf. B 101 319–24
[81] Zhou N L, Gu H, Tang F F, Li W X, Chen Y Y and
Yuan J 2013 Biocompatibility of novel carboxylated
graphene oxide-glutamic acid complexes J. Mater. Sci. 48
7097–103
[82] Lee D Y, Khatun Z, Lee J-H, Lee Y-K and In I 2011 Blood
compatible graphene/heparin conjugate through noncovalent
chemistry Biomacromolecules 12 336–41
[83] Stout D A, Yoo J, Santiago-Miranda A N and Webster T J
2012 Mechanisms of greater cardiomyocyte functions on
conductive nanoengineered composites for cardiovascular
applications Int. J. Nanomed. 7 5653–69
[84] Kane A B and Hurt R H 2008 Nanotoxicology: the asbestos
analogy revisited Nat Nanotechnol. 3 378–9
[85] Kostarelos K 2008 The long and short of carbon nanotube
toxicity Nat. Biotech. 26 774–6
[86] Lison D andMuller J 2008 To the Editor Toxicol. Sci. 101 179–80
[87] Shvedova A A et al 2009 Mechanisms of pulmonary toxicity
and medical applications of carbon nanotubes: two faces of
Janus? Pharmacol. Ther. 121 192–204
[88] Pacurari M, Castranova V and Vallyathan V 2010 Single- and
multi-wall carbon nanotubes versus asbestos: are the carbon
nanotubes a new health risk to humans? J. Toxicol. Environ.
Health A 73 378–95
[89] Sanchez V C, Jachak A, Hurt R H and Kane A B 2012
Biological interactions of graphene-family nanomaterials: an
interdisciplinary review Chem. Res. Toxicol. 25 15–34
[90] Alenius H, Catalán J, Lindberg H, Norppa H, Palomäki J and
Savolainen K 2014 Nanomaterials and human health
Handbook of Nanosafety (San Diego, CA: Academic)
pp 59–133 ch 3
[91] Filho J D S et al 2014 Evaluation of carbon nanotubes
network toxicity in zebrafish (Danio rerio) model Environ.
Res. 134 9–16
[92] Chang Y et al 2011 In vitro toxicity evaluation of graphene
oxide on A549 cells Toxicol. Lett. 200 201–10
[93] Ryoo S R, Kim Y K, Kim M H and Min D H 2010 Behaviors
of NIH-3T3 fibroblasts on graphene/carbon nanotubes:
proliferation, focal adhesion, and gene transfection studies
ACS Nano 4 6587–98
[94] Fubini B, Ghiazza M and Fenoglio I 2010 Physico-chemical
features of engineered nanoparticles relevant to their toxicity
Nanotoxicology 4 347–63
[95] Sakamoto Y et al 2009 Induction of mesothelioma by a single
intrascrotal administration of multi-wall carbon nanotube in
intact male Fischer 344 rats J. Toxicol. Sci. 34 65–76
[96] Ma-Hock L et al 2009 Inhalation toxicity of multiwall carbon
nanotubes in rats exposed for 3 months Toxicol. Sci.:
Official J. Soc. Toxicol. 112 468–81
[97] Takagi A et al 2008 Induction of mesothelioma in p53+/−
mouse by intraperitoneal application of multi-wall carbon
nanotube J. Toxicol. Sci. 33 105–16
[98] Poland C A et al 2008 Carbon nanotubes introduced into the
abdominal cavity of mice show asbestos-like pathogenicity
in a pilot study Nat. Nanotechnol. 3 423–8
[99] Bianco A, Kostarelos K and Prato M 2011 Making carbon
nanotubes biocompatible and biodegradable Chem.
Commun. 47 10182–8
[100] Vardharajula S et al 2012 Functionalized carbon nanotubes:
biomedical applications Int. J. Nanomed. 7 5361–74
[101] Chen J-P and Chang Y-S 2011 Preparation and
characterization of composite nanofibers of
polycaprolactone and nano-hydroxyapatite for osteogenic
differentiation of mesenchymal stem cells Colloids Surf. B
86 169–75
[102] Li K 2010 Fabrication and characterization of polymer-
hydroxyapatite nanocomposites for bone tissue engineering
Thesis
[103] Fisher J P et al 2002 Soft and hard tissue response to
photocrosslinked poly(propylene fumarate) scaffolds in a
rabbit model J. Biomed. Mater. Res. 59 547–56
[104] Solheim E, Sudmann B, Bang G and Sudmann E 2000
Biocompatibility and effect on osteogenesis of poly(ortho
ester) compared to poly(DL-lactic acid) J. Biomed. Mater.
Res. 49 257–63
[105] Mistry A S, Mikos A G and Jansen J A 2007 Degradation and
biocompatibility of a poly(propylene fumarate)-based/
alumoxane nanocomposite for bone tissue engineering J.
Biomed. Mater. Res. A 83 940–53
[106] Zhang S M, Cui F Z, Liao S S, Zhu Y and Han L 2003
Synthesis and biocompatibility of porous nano-
hydroxyapatite/collagen/alginate composite J. Mater. Sci.
Mater. Med. 14 641–5
[107] Edwards S L, Church J S, Werkmeister J A and Ramshaw J A
2009 Tubular micro-scale multi-walled carbon nanotube-
based scaffolds for tissue engineering Biomaterials 30
1725–31
18
Sci. Technol. Adv. Mater. 16 (2015) 033504 M V Vellayappan et al
